William Powers

Dec 4, 2024 | outsourcedpharma.com | Louis Garguilo |William Powers |Jenny Minigh |inSeption Group

Whitepaper: Nose to Brain (N2B) Drug Delivery – Benefits and Challenges. The brain and central nervous system (CNS) are critical yet challenging targets for drug delivery due to barriers like the blood-brain barrier. Explore the benefits and challenges of Nose to Brain (N2B) delivery, including delivery targets, transport mechanisms, liquid and dry powder formulations, and the development of nasal dosage forms.

Nov 19, 2024 | pharmaceuticalonline.com | William Powers |Brian Anderson |Daniel Mateo-Ortiz

Three Breakthrough Technologies in the Drug Manufacturing ProcessInnovation never stops, especially in drug development. Right now, there's a lot happening in this field with significant advances for pharma formulation and manufacturing. Are you ready for the future? We’ll give you a quick breakdown of three breakthrough technologies for solid dose formulation: 3D Printing, Continuous Manufacturing and Predictive Formulation.

Oct 9, 2024 | outsourcedpharma.com | William Powers |Louis Garguilo

By William Powers, Senior Director of Business Development Across industries, the imperative to reduce carbon emissions to help negate the effects of climate change is top of mind, and the pharmaceutical industry is no exception. CDMOs and suppliers alike are facing a challenging imperative: reduce the carbon footprint while maintaining the highest standards of quality and efficiency to ensure program success and patient well-being.

Mar 13, 2023 | dockets.justia.com | William Powers

February 22, 2023 Order [non-document] granting Plaintiff's Motion for appearance pro hac vice by attorney Matthew G. Howells for Commonwealth of Virginia. Local Rule 5.1(c) requires that attorneys register for NextGen CM/ECF and file and receive all documents electronically. NextGen CM/ECF registration can be done online at www.pacer.gov.